Literature DB >> 16894463

Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction.

Jaap Jan J Smit1, Arnoud W J van 't Hof, Menko Jan de Boer, Jan C A Hoorntje, Jan Henk E Dambrink, A T Marcel Gosselink, Jan Paul Ottervanger, J J Evelien Kolkman, Harry Suryapranata.   

Abstract

Subacute thrombosis (SAT) is a major concern in patients undergoing percutaneous coronary intervention (PCI). So far, only little data has been available on characteristics and outcome of patients with SAT after primary PCI for ST elevation myocardial infarction (STEMI). From 1997-2001, 1,548 unselected consecutive patients underwent primary PCI for STEMI as part of a randomized controlled trial stenting vs. balloon angioplasty. All patients received acetylsalicylic acid (500 mg i.v.) and heparin (5,000 IU) before the procedure. After stenting, all patients received ticlopidine 250 mg daily (before July 1999) or clopidogrel 75 mg daily (after July 1999) for one month. Five percent of patients received glycoprotein IIb/IIIa blockers. We prospectively recorded incidence and characteristics of patients with SAT during one year follow-up. SAT occurred in 4.1% (63/1548) and reinfarction in 6.0% of patients. The incidence of SAT did not change over time (1997: 8/175[4.6%],1998: 8/325 [2.5%],1999: 13/358 [3.6%], 2000: 22/426 [5.2%], 2001: 12/264 [4.5%]). SAT occurred in 39/63(62%) patients during hospital stay. The incidence did not differ between patients after ticlopidine 23/681 (3.4%) or clopidogrel 40/867 (4.6%, p = 0.222). Univariate predictors of SAT were: patients with an LAD stenosis (5.4% vs. 2.9%, p = 0.016), with Killip class >1 at presentation (8.6% vs. 3.7%, p = 0.007) and in patients who received a stent (5.1% vs. 2.7%, p = 0.022). After multivariate analysis, Killip class >1 on admission was the only independent predictor of SAT(OR 2.26, 95% CI 1.14-4.47, p = 0.019). SAT was associated with a higher mortality at long-term follow-up (15% vs. 7%, p = 0.026). In a prospectively recorded, unselected consecutive series of patients undergoing PCI for STEMI, SAT occurred in 4.1% of patients at one-year follow-up. Signs of heart failure on admission, anterior myocardial infarction and stenting were predictors of SAT.

Entities:  

Mesh:

Year:  2006        PMID: 16894463

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

Review 1.  Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials.

Authors:  Jun Chen; Haoyu Meng; Lei Xu; Jie Liu; Deyu Kong; Pengsheng Chen; Xiaoxuan Gong; Jianling Bai; Fengwei Zou; Zhijian Yang; Chunjian Li; John W Eikelboom
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

2.  Total occlusion of the internal carotid artery by subacute in-stent thrombosis and subsequent spontaneous recanalization after stent-assisted coil embolization.

Authors:  Cheol Young Lee; Chang-Woo Ryu; Jun Seok Koh; Eui Jong Kim
Journal:  Neurointervention       Date:  2011-02-28

3.  Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction.

Authors:  Ming Gao; Yang Zheng; Weihua Zhang; Yi Cheng; Lin Wang; Ling Qin
Journal:  Lipids Health Dis       Date:  2017-01-23       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.